MyFinsight
Home
Blog
About
Back
Income Statement
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
source: myfinsight.com
Net loss
-$57,939K
(-37.03%↓ Y/Y)
Interest income
$7,104K
(-13.65%↓ Y/Y)
Loss from operations
-$56,308K
(-19.29%↓ Y/Y)
Interest expense
$7,940K
(143.26%↑ Y/Y)
Product revenue, net
$364,252K
(71.17%↑ Y/Y)
Other expense, net
-$795K
(-1792.86%↓ Y/Y)
Total operating
expenses
$420,560K
(61.75%↑ Y/Y)
Selling, general and
administrative
$289,375K
(47.00%↑ Y/Y)
Research and development
$91,178K
(68.60%↑ Y/Y)
Cost of sales
$40,007K
(341.33%↑ Y/Y)
Back